Bioaccessibility of Cafestol from Coffee Brew: A Metabolic Study Employing an In Vitro Digestion Model and LC-HRMS
2024

Study on Cafestol in Coffee Brew

publication Evidence: moderate

Author Information

Author(s): Ana Brand, Ana Silva, Cyrus Andriolo, Caroline Mellinger, Thaís Uekane, Rafael Garrett, Claudia Rezende

Primary Institution: Instituto de Química, Universidade Federal do Rio de Janeiro

Hypothesis

This study aimed to quantify cafestol in boiled coffee brew, assess its bioaccessibility, and investigate the metabolites formed during digestion.

Conclusion

Cafestol is bioaccessible and mainly absorbed in its alcohol form during digestion.

Supporting Evidence

  • Cafestol content in boiled coffee brew ranged from 127.47 to 132.65 mg L–1.
  • The bioaccessibility of cafestol from boiled coffee brew was found to be 93.65%.
  • A novel metabolite, 17-oxo-cafestol, was identified during the digestion process.

Takeaway

Cafestol, a compound in coffee, is easy for our bodies to absorb, especially in its alcohol form after we drink coffee.

Methodology

The study used an in vitro digestion model to assess the bioaccessibility of cafestol and analyzed metabolites using liquid chromatography coupled to high-resolution mass spectrometry.

Limitations

The study's findings may not fully represent human digestion due to the in vitro model used.

Digital Object Identifier (DOI)

10.1021/acs.jafc.4c06411

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication